| Literature DB >> 27508257 |
Nasim Golkar1, Soliman Mohammadi Samani2, Ali Mohammad Tamaddon3.
Abstract
In this data article, carboxyfluorescein-loaded liposomes were prepared and purified from free carboxyfluorescein using gel filtration chromatography in the first part. In the next part, following preparation of anti-VEGF siRNA loaded liposomes incorporating hydrophobically modified G2 PAMAM dendrimer (G2-Chol40%) (Golkar et al., 2016) [1], the cell growth inhibition induced by the formulations (siRNA/Metafectene complexes and siRNA loaded liposomes incorporating hydrophobic G2) was evaluated at two exposure times through MTT assay in a breast cancer cell (SKBR-3) and compared by two-way ANOVA.Entities:
Keywords: Anti-VEGF siRNA; Cell growth inhibition; Liposome; Polyamidoaminedendrimer
Year: 2016 PMID: 27508257 PMCID: PMC4969245 DOI: 10.1016/j.dib.2016.06.064
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Carboxyfluorescein 38 mM in 25 mM HEPES buffer pH=7.4 (A), carboxy fluorescein encapsulated 5 mM liposomes in 25 mM HEPES buffer pH=7.4 (B), and gel filtration Sephadex G50 column (C).
Fig. 2Gel filtration chromatograms of 38 mM free carboxy fluorescein, 5 mM rhodamine-labeled liposomes (1 mol% rhodamine-PE), and carboxyfluorescein encapsulated liposomes. Fractions of 7-11 and 13-50 (each fraction=400 µl) corresponds to the liposomes and free carboxyfluorescein eluted from the Sephadex G50 column (1 cm×5 cm, diameter×length) with 20 mM HEPES buffered saline solution (pH=7.4).
Fig. 3Growth inhibition following 4 or 13 h exposure of SKBR-3 cells with different concentrations of (A) anti-VEGF siRNA (siRNA-AS)/Metafectene complexes and (B) anti-VEGF siRNA (siRNA-AS) loaded liposomes incorporating G2-Chol40%. The cells were then incubated with fresh complete medium for 72 h at 37 °C before MTT assay. (C) MTT-based growth inhibition assay of SKBR-3 cells with various concentrations of anti-VEGF siRNA (siRNA-AS)/Metafectene complexes. Data represents mean±SD for triplicates.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran |
| Data accessibility |